![](/img/cover-not-exists.png)
EORTC 10968: a phase I clinical and pharmacokinetic study of polyethylene glycol liposomal doxorubicin (Caelyx(R), Doxil(R)) at a 6-week interval in patients with metastatic breast cancer
Hamilton, A., Biganzoli, L., Coleman, R., Mauriac, L., Hennebert, P., Awada, A., Nooij, M., Beex, L., Piccart, M., Van Hoorebeeck, I., Bruning, P., de Valeriola, D.Volume:
13
Language:
english
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdf157
Date:
June, 2002
File:
PDF, 105 KB
english, 2002